Compounding Animal Drugs from
Bulk Drug Substances
New
collection (Request for a new OMB Control Number)
No
Regular
04/14/2022
Requested
Previously Approved
36 Months From Approved
8,505,000
0
144,585
0
0
0
This information collection accounts
for burden that may be attendant to recommendations discussed in
FDA guidance applicable to pharmacists and veterinarians who
compound animal drugs from bulk drug substances.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.